Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Onconetix (ONCO) Other Non-Current Liabilities (2023 - 2025)

Historic Other Non-Current Liabilities for Onconetix (ONCO) over the last 3 years, with Q3 2025 value amounting to $12.8 million.

  • Onconetix's Other Non-Current Liabilities rose 4918846.15% to $12.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $12.8 million, marking a year-over-year increase of 4918846.15%. This contributed to the annual value of $32982.0 for FY2024, which is 114884.51% up from last year.
  • According to the latest figures from Q3 2025, Onconetix's Other Non-Current Liabilities is $12.8 million, which was up 4918846.15% from $53113.0 recorded in Q2 2025.
  • Onconetix's Other Non-Current Liabilities' 5-year high stood at $12.8 million during Q3 2025, with a 5-year trough of $2641.0 in Q4 2023.
  • Its 3-year average for Other Non-Current Liabilities is $2.2 million, with a median of $42933.0 in 2024.
  • As far as peak fluctuations go, Onconetix's Other Non-Current Liabilities soared by 114884.51% in 2024, and later surged by 4918846.15% in 2025.
  • Onconetix's Other Non-Current Liabilities (Quarter) stood at $2641.0 in 2023, then skyrocketed by 1148.85% to $32982.0 in 2024, then soared by 38754.53% to $12.8 million in 2025.
  • Its Other Non-Current Liabilities was $12.8 million in Q3 2025, compared to $53113.0 in Q2 2025 and $52884.0 in Q1 2025.